drugset / Trial / NCT00752258

A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows

NCT00752258 ↗

Phase 3 Completed 576 enrolled Mentor Worldwide, LLC Synteract, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

The overall purpose of this study is to evaluate the long-term safety of repeat treatment with an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines.

Timeline

Start
2008-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mentor Purified Toxin Unknown 30 unknown Intramuscular

Indications

No indication recorded.